Every Form 4 that MS CALL WTS EURO 2026 (MSTLW) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow MSTLW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MSTLW filings page.
NALLY DENNIS M reported acquisition or exercise transactions in this Form 4 filing.
Morgan Stanley director Dennis M. Nally reported two stock-based compensation awards of Common Stock. On June 1, 2026, he received 345.304 shares as restricted stock units priced at $209.9594 per share under the Morgan Stanley Directors' Equity Capital Accumulation Plan.
He also received 1,309.777 deferred stock units under the same directors' plan in lieu of cash retainers. Both the restricted stock units and deferred stock units are convertible into shares of Common Stock on a 1-to-1 basis, reflecting routine equity compensation rather than open-market buying or selling.
WILKINS RAYFORD JR reported acquisition or exercise transactions in this Form 4 filing.
Morgan Stanley director Rayford Wilkins Jr received an equity award of 1,309.777 restricted stock units, which are convertible into Common Stock on a 1-to-1 basis under the Morgan Stanley Directors' Equity Capital Accumulation Plan. The award was granted at $0.00 per share as compensation rather than an open-market purchase.
Following this grant, Wilkins directly holds 78,268.886 shares of Morgan Stanley Common Stock. No derivative option positions are reported in this filing, so the change reflects an increase in his direct equity stake through stock-based compensation.
Morgan Stanley director Megan Butler reported routine equity compensation activity. She received a grant of 1,309.777 shares of Common Stock in the form of restricted stock units under the Morgan Stanley Directors' Equity Capital Accumulation Plan, at no cash cost. To cover taxes upon conversion of these stock units into shares, 190 shares were withheld at a price of $209.9594 per share, a tax-withholding disposition rather than an open-market sale. After these transactions, Butler directly holds 5,829.147 shares of Morgan Stanley common stock.
Morgan Stanley director Erika H. James received a grant of 1,309.777 restricted stock units under the Morgan Stanley Directors' Equity Capital Accumulation Plan. These units convert into Common Stock on a 1-for-1 basis and increase her direct holdings to 13,252.773 shares, reflecting equity-based compensation rather than an open-market purchase.
Morgan Stanley director Lynn J. Good received stock-based compensation awards in the form of common stock and stock units. On 2026-06-01, she acquired 273.862 shares of common stock at $209.9594 per share and 1,309.777 additional shares at no cash cost to her.
Footnotes explain these are restricted stock units and deferred stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan, each convertible into common stock on a 1-to-1 basis. These awards are compensation-related grants, not open-market share purchases.
Morgan Stanley director Perry M. Traquina reported receiving stock-based compensation rather than trading shares in the market. On 2026-06-01, Traquina acquired 369.119 shares of Morgan Stanley common stock at $209.9594 per share as a grant.
A separate award of 1,309.777 deferred stock units was also reported at a price of $0.00, reflecting units granted in lieu of cash retainers for board service. Footnotes explain these are restricted and deferred stock units under the Morgan Stanley Directors' Equity Capital Accumulation Plan, each convertible into one share of common stock.
The filing characterizes both entries as grants or awards, not open-market purchases or sales, and shows Traquina holding 90,963.319 shares of common stock directly following one of the reported transactions.
Morgan Stanley director Douglas L. Peterson reported two equity awards of Common Stock. On June 1, 2026, he acquired 273.862 shares at a grant value of $209.9594 per share, plus 1,309.777 deferred stock units granted in lieu of cash retainers, both under the Morgan Stanley Directors' Equity Capital Accumulation Plan.
Miscik Judith A reported acquisition or exercise transactions in this Form 4 filing.
Morgan Stanley director Judith A. Miscik received a grant of 1,309.777 shares of Common Stock on June 1, 2026 as part of her director compensation. The award is in the form of restricted stock units under the Morgan Stanley Directors' Equity Capital Accumulation Plan, convertible into Common Stock on a 1-to-1 basis.
Following this grant, she directly holds a total of 66,494.080 shares of Morgan Stanley Common Stock. This filing reflects a compensation-related equity award rather than an open-market purchase or sale.
Morgan Stanley director Robert H. Herz reported an award of 1,309.777 shares of Common Stock on the company’s Form 4. The award was made at a stated price of $0.00 per share as a compensation-related grant rather than an open-market purchase.
The filing shows his directly held Common Stock position increasing to 102,562.562 shares following this transaction. A footnote explains that the grant consists of restricted stock units issued under the Morgan Stanley Directors' Equity Capital Accumulation Plan, which convert into Common Stock on a 1-for-1 basis.
Leibowitz Shelley B reported acquisition or exercise transactions in this Form 4 filing.
Morgan Stanley director Shelley B. Leibowitz received an equity award of 1,309.777 shares of Common Stock. This was a grant with no cash price per share, bringing her direct holdings to 48,369.693 shares after the transaction. The award consists of restricted stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan, which are convertible into Common Stock on a one-for-one basis.
Morgan Stanley director Thomas H. Glocer received equity awards in the form of company stock. On June 1, 2026, he acquired 512.004 shares of Common Stock at an indicated value of $209.9594 per share and 1,309.777 additional shares at no stated price.
These awards relate to restricted and deferred stock units under the Morgan Stanley Directors' Equity Capital Accumulation Plan, which are convertible into Common Stock on a 1-to-1 basis. Following the transactions, he directly holds 124,549.792 shares of Morgan Stanley Common Stock.
Morgan Stanley director Mary L. Schapiro received an equity award of 1,309.777 shares of Common Stock on June 1, 2026. The award consists of restricted stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan, which convert into Common Stock on a 1-to-1 basis.
These shares were granted as compensation at no cash cost per share. Following this award, Schapiro directly holds a total of 41,842.588 shares of Morgan Stanley Common Stock. The filing does not report any open-market purchases or sales, only this grant/award acquisition.
Morgan Stanley Chief Legal/Admin Officer Eric F. Grossman reported selling 11,118 shares of Common Stock in open-market transactions. The sales occurred on April 20, 2026 in two equal blocks of 5,559 shares at prices of $191.50 and $190.00 per share. After these trades, he continues to hold well over 160,000 Morgan Stanley shares directly, indicating the transactions represent a relatively small portion of his overall stake.
Morgan Stanley Co-President Daniel A. Simkowitz reported an insider transaction involving the company’s common stock. He made a bona fide gift of 8,000 shares and completed an open-market sale of 14,690 shares at a weighted average price of $189.2435 per share. Following these transactions, he directly holds 365,802.079 shares of Morgan Stanley common stock and has an additional 1,805.331 shares held indirectly through a 401(k) Plan.
Morgan Stanley Co-President Andrew M. Saperstein reported selling 51,668 shares of Morgan Stanley common stock in a series of open-market transactions on April 16, 2026. The sales were executed at weighted average prices, with disclosed ranges generally between $186.77 and $192.34 per share.
After these transactions, Saperstein directly holds 282,142.385 shares of Morgan Stanley common stock, so the filing reflects a partial reduction rather than a full exit from his equity position.
Morgan Stanley Chief Financial Officer Sharon Yeshaya reported a routine equity compensation event involving performance stock units. She acquired 17,399 shares of common stock at a stated price of $0.00 per share, reflecting shares earned under a performance stock unit award tied to relative return on tangible common equity.
To cover tax obligations from this PSU conversion, 9,622 shares were disposed of at $160.89 per share through share withholding, not an open-market sale. After these transactions, she holds 151,659.2 shares of Morgan Stanley common stock directly.
Morgan Stanley Co-President Daniel A. Simkowitz reported compensation-related stock activity. He received a grant of 32,865 shares of common stock earned under a performance stock unit award tied to relative return on tangible common equity. On the same date, 18,175 shares were withheld at $160.89 per share to cover taxes on the award conversion, so this disposition was not an open-market sale. After these entries, he directly holds 388,492.079 shares of common stock and indirectly holds 1,805.331 shares through a 401(k) plan.
Morgan Stanley Co-President Andrew M. Saperstein reported a compensation-related stock transaction. He received a grant of 52,777 shares of common stock at no cost, earned based on the company’s achievement of pre-established relative return on tangible common equity performance goals tied to a performance stock unit award granted on January 18, 2023.
To cover taxes on the PSU conversion, 26,943 shares were withheld at a price of $160.89 per share, a non-market, tax-withholding disposition rather than an open-market sale. After these entries, Saperstein directly owns 333,810.385 shares of Morgan Stanley common stock.
Morgan Stanley executive Michael A. Pizzi, Head of Technology & Operations, received a grant of 16,432 shares of common stock on March 12, 2026. The shares were earned under a performance stock unit award tied to pre-established return-on-tangible-common-equity goals. To cover taxes on this conversion, 7,900 shares were withheld at a price of $160.89 per share, resulting in a net increase in his direct holdings to 145,467.42 shares of common stock.
Morgan Stanley Chief Legal/Admin Officer Eric F. Grossman received a grant of 22,715 shares of common stock on March 12, 2026 at no cost, earned from a performance stock unit award granted on January 18, 2023 based on pre-established return-on-tangible-common-equity criteria.
On the same date, 11,597 shares were withheld at $160.89 per share to cover tax obligations tied to that performance award conversion. After these compensation-related transactions, Grossman directly holds 186,079.952 shares of Morgan Stanley common stock.
Morgan Stanley Chief Client Officer Mandell Crawley received a stock award and had shares withheld for taxes. On the same date, he acquired 9,666 shares of common stock at no cost when a January 18, 2023 performance stock unit award vested based on pre-set return-on-tangible-common-equity goals. The company then withheld 4,935 shares at a price of $160.89 per share to cover related tax obligations. After these compensation-related transactions, Crawley directly holds 78,657.888 shares of Morgan Stanley common stock.
Morgan Stanley Chairman and CEO Edward Pick reported a stock-based compensation event involving the company’s common stock. He received a grant of 60,897 shares on March 12, 2026 at $0.0000 per share, earned based on the company’s achievement of pre-established relative return on tangible common equity performance criteria for a prior performance stock unit award.
To cover tax obligations upon conversion of this performance stock unit award, 33,677 shares were withheld at a price of $160.89 per share. After these transactions, he directly owned 666,248.764 shares of common stock, with additional indirect holdings of 4,298.477 shares through a 401(k) plan and 104,963 shares through a Grantor Retained Annuity Trust.
Morgan Stanley Co-President Daniel A. Simkowitz reported equity compensation activity involving company common stock. He acquired 32,865 shares on February 19, 2026 at $0.0000 per share, described as shares earned based on Morgan Stanley’s achievement of pre-established average return on tangible common equity performance criteria tied to a performance stock unit award granted on January 18, 2023.
On the same date, 18,175 shares at $176.59 per share were disposed of to satisfy taxes upon conversion of that performance stock unit award. Following these transactions, he directly owned 373,802.079 shares of common stock. A separate line shows 1,805.331 shares held indirectly through a 401(k) plan.
Morgan Stanley Co-President Andrew M. Saperstein reported mixed equity compensation activity in Morgan Stanley common stock. He acquired 52,777 shares on a grant or award basis at $0.00 per share, earned based on the company’s achievement of pre-established average return on tangible common equity performance criteria tied to a January 18, 2023 performance stock unit award. He then disposed of 26,943 shares at $176.59 per share, with the shares withheld to satisfy taxes upon conversion of that performance stock unit award. Following these transactions, he directly owned 307,976.385 shares of Morgan Stanley common stock.
Morgan Stanley Chief Legal/Admin Officer Eric F. Grossman reported equity compensation activity in common stock. He acquired 22,715 shares at $0.0000 per share as a grant tied to the company’s achievement of pre-established return on tangible common equity performance criteria from a January 18, 2023 performance stock unit award. To cover associated tax obligations on this conversion, 11,597 shares were disposed at $176.5900 per share through share withholding. After these transactions, he held 180,428.209 common shares directly.
Morgan Stanley Chief Client Officer Mandell Crawley reported a mix of equity award activity and related tax withholding. On February 19, 2026, he acquired 9,666 shares of common stock at $0.00 per share as a grant/award, earned based on the company’s achievement of pre-established average return on tangible common equity performance criteria tied to a performance stock unit award granted on January 18, 2023. On the same date, 4,935 shares of common stock were disposed of at $176.59 per share to satisfy tax obligations upon conversion of that performance award. Following these transactions, Crawley held 73,926.888 shares of Morgan Stanley common stock directly.
Morgan Stanley Chairman and CEO Edward Pick reported equity compensation activity in company stock. He acquired 60,897 shares of common stock at a price of $0.0000 per share as a grant or award, based on the company’s achievement of pre-established average return on tangible common equity performance criteria for a performance stock unit award originally granted on January 18, 2023.
On the same date, 33,731 shares of common stock were disposed of at $176.5900 per share to satisfy tax withholding obligations upon conversion of that performance stock unit award. After these transactions, he held 639,028.764 shares of common stock directly, plus additional indirect holdings of 4,298.477 shares through a 401(k) plan and 104,963 shares through a grantor retained annuity trust.
Morgan Stanley Co-President Daniel A. Simkowitz reported a sale of company stock. On January 30, 2026, he sold 32,968 shares of Morgan Stanley common stock in an open-market transaction at a weighted average price of $182.6108, with individual trade prices ranging from $182.06 to $183.05.
Following this sale, he beneficially owns 357,342.406 shares of Morgan Stanley common stock directly and 1,794.818 shares indirectly through a 401(k) plan.
Morgan Stanley Chief Financial Officer Sharon Yeshaya reported a sale of common stock in the company. On January 20, 2026, Yeshaya sold 15,838 shares of Morgan Stanley common stock in an open-market transaction, reported with code “S” for a sale. The weighted average sale price was $185.7669 per share, with individual trades executed between $185.67 and $185.98 per share.
After this transaction, Yeshaya beneficially owned 135,304.336 shares of Morgan Stanley common stock in direct ownership. The filing notes that detailed price and size information for each individual trade in the reported price range is available upon request from Morgan Stanley, its security holders, or the SEC staff.
Morgan Stanley Chief Risk Officer Charles A. Smith reported selling common stock in a recent insider transaction. On January 20, 2026, he sold 8,500 shares of Morgan Stanley common stock at a weighted average price of $182.0807 per share. The filing notes that these shares were sold in multiple trades at prices ranging from $182.0401 to $182.1301.
After this sale, Smith reported owning 119,127.619 shares of Morgan Stanley common stock directly. He also reported an indirect holding of 5,494.73 shares through a 401(k) plan. The filing states that detailed trade-by-trade pricing information is available upon request from Morgan Stanley, its security holders, or the SEC staff.
Morgan Stanley Co-President Andrew M. Saperstein reported multiple open-market sales of the company’s common stock on January 20, 2026. The Form 4 shows several separate transactions, each coded "S" for sale, with block sizes ranging from 500 shares to 11,430 shares at reported weighted average prices such as $181.8518, $182.6338, $184.1265, $184.9381, $185.9112, and $186.5960 per share. After these transactions, Saperstein directly beneficially owned 280,480.994 Morgan Stanley common shares.
For each block, the filing notes that the reported price is a weighted average of multiple trades, with actual execution prices ranging from $181.34 to $186.65. The reporting person undertakes to provide full trade-by-trade details within these ranges to Morgan Stanley, its security holders, or the SEC staff upon request.
Morgan Stanley Head of Technology & Operations Michael A. Pizzi reported a sale of Morgan Stanley common stock. On January 20, 2026, he sold 20,000 shares of common stock at a price of $184.55 per share, according to the Form 4 filing. After this transaction, he beneficially owned 127,872.293 shares of Morgan Stanley common stock, held in direct ownership. The filing reflects this as a non-derivative transaction coded as a sale and shows no derivative securities activity.
Morgan Stanley director files amended insider trading report correcting prior gift details. The amended Form 4 now shows that on 01/20/2026 a bona fide gift of 542 shares of Morgan Stanley common stock was made at a reported price of $0, reflecting that this was a gift rather than an open-market sale. Following this transaction, the reporting person directly beneficially owns 11,845.004 shares of Morgan Stanley common stock. The amendment updates the previously filed report from 01/16/2026 to correct the transaction date, the number of shares transferred, and the post-transaction holdings.
Morgan Stanley Chief Legal/Admin Officer Eric F. Grossman reported two transactions in the company’s common stock dated January 20, 2026. He sold 21,555 shares at a weighted average price of $184.0008 per share, in multiple trades within a price range of $184.00 to $184.02. After this sale, he held 171,005.085 shares.
On the same date, Grossman also reported a transaction coded "G" for 2,495 shares of common stock at a reported price of $0, which reduced his holdings to 168,510.085 shares directly owned. He has committed to provide detailed trade breakdowns to Morgan Stanley, its security holders, or the SEC staff upon request.
Morgan Stanley’s Chief Client Officer, Crawley Mandell, reported selling a total of 7,860 shares of the company’s common stock on January 20, 2026. The sales were executed in several market transactions, with weighted average prices ranging from about $181.8899 to $185.9396, as detailed in the filing footnotes, which note that each line reflects a weighted average of multiple individual trades within stated price ranges.
After these transactions, Mandell directly owned 68,788.495 shares of Morgan Stanley common stock. All reported positions are non-derivative common stock, and there were no derivative security transactions disclosed in this filing.
Morgan Stanley director reported receiving additional equity compensation in the form of deferred stock units. On 12/01/2025, the reporting person acquired 459.241 shares of Morgan Stanley common stock at a price of $168.757 per share, bringing total directly owned shares to 88,666.394.
The units were granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan in lieu of cash retainers for service on the Board of Directors. Each deferred stock unit is convertible into one share of common stock, aligning director compensation with shareholder interests through equity rather than cash.
Morgan Stanley director reports deferred stock unit grant tied to service on the company’s board. On 12/01/2025, the director acquired 429.612 shares of Morgan Stanley common stock in the form of deferred stock units at a price of $168.757 per share. These units were granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan in lieu of cash retainers for board service and are convertible into common stock on a 1-to-1 basis.
Following this grant, the director beneficially owns 45,137.158 shares of Morgan Stanley common stock in direct form. The filing reflects a routine equity-based compensation transaction for a board member rather than an open-market purchase or sale.
Morgan Stanley director reports deferred stock unit grant
A Morgan Stanley director filed a Form 4 reporting an award of 227.151 deferred stock units of Morgan Stanley common stock on 12/01/2025. The units were acquired at a price of $168.757 per share and increased the director’s beneficial ownership to 1,895.761 shares held directly.
The filing explains that these deferred stock units were granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan in lieu of cash retainers for serving on the Board of Directors. Each stock unit is convertible into one share of Morgan Stanley common stock.
Morgan Stanley (MS) reported an insider transaction on Form 4. A director disclosed a disposition coded “G” of 1,800 shares of Common Stock on 11/07/2025 at a reported price of $0. Following this transaction, the reporting person beneficially owns 46,883.484 shares, held directly.
The filing indicates the form was submitted by an attorney-in-fact. No derivative securities were reported in Table II.
Morgan Stanley (MS) filed a Form 4 for its Co‑President reporting a bona fide gift of common stock. On 10/29/2025, the insider disposed of 10,000 shares of Common Stock at $0 per share under transaction code G (gift).
Following the transaction, the insider beneficially owns 383,757.251 shares directly. In addition, 1,784.419 shares are held indirectly by a 401(k) Plan. This filing reflects a transfer by gift rather than an open-market sale.
Morgan Stanley (MS) disclosed a Form 4 showing its Chairman and CEO executed two transactions on 10/31/2025. The insider sold 100,000 shares of common stock at a weighted average price of $164.3444, with individual trades ranging from $164.11 to $164.65. The filing also reports a gift of 123 shares.
Following these transactions, the insider directly beneficially owns 574,863.015 shares. Additional indirect holdings include 4,248.685 shares via a 401(k) plan and 181,976 shares held by a Grantor Retained Annuity Trust.
Morgan Stanley (MS) filed a Form 4 reporting an insider transaction by its Chief Accounting Officer. On 10/16/2025, a transaction coded “F” was reported involving 49 shares of common stock at $162.65 per share. Following this transaction, the reporting person directly owned 8,740.667 shares.
The filing indicates it was submitted by one reporting person and reflects direct ownership. No derivative securities transactions were reported.